NCT07597135
Comparative Evaluation of Alb PRF Versus Connective Tissue Graft in Reconstruction of Deficient Interdental Papilla
StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Start date: Jun 20, 2026 to Dec 12, 2026
- Eligibility criteria expanded, about 2 words
- Primary completion moved earlier from Sep 20, 2028 to Dec 12, 2027
- Study completion moved earlier from Dec 20, 2028 to Dec 22, 2027
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
papillary height measured from apical part of contact point to tip of papilla (CP-TP)
Timeframe: from enrollment, 3 months, 6months, 9months, 12months
Arms and interventions
connective tissue graftActive comparator
Albumin plasma rich fibrin membraneExperimental
Biologicals: Albumin (5% serum-protein solution containing immunoglobulins), connective tissue graft